Rapid Micro Biosystems Inc Class A RPID
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.09
- Day Range
- $2.00–2.09
- 52-Week Range
- $1.66–4.94
- Bid/Ask
- $2.05 / $2.36
- Shares Outstanding
- 49.82M
- Market Cap
- $103.13M
- Volume/Avg
- 139,092 / 182,985
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.71
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 171
- Website
- https://www.rapidmicrobio.com
Valuation
|
Metric
|
RPID
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.64 |
Price/Sales | 2.71 |
Price/Cash Flow | — |
Price/Earnings
RPID
Financial Strength
|
Metric
|
RPID
|
|---|---|
Quick Ratio | 1.54 |
Current Ratio | 2.57 |
Interest Coverage | −115.50 |
Quick Ratio
RPID
Profitability
|
Metric
|
RPID
|
|---|---|
Return on Assets (Normalized) | −61.16% |
Return on Equity (Normalized) | −107.37% |
Return on Invested Capital (Normalized) | −77.16% |
Return on Assets
RPID
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|pw?kmM% | LOCK|T@?b | $175B | |||
| Stryker Corp
SYK
| LOCK|Ms%$sZvk | LOCK|&Lz | $123B | |||
| Medtronic PLC
MDT
| LOCK|#^NY!WZ | LOCK|%pm> | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|yGRj>q | LOCK|ndQW | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|Rp#zCQX | LOCK|xK<H | $49B | |||
| DexCom Inc
DXCM
| LOCK|c>?mV><g | LOCK|#<hg | $30B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|XkMDBD | LOCK|f#C | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|cc | LOCK|B< | $26B | |||
| Steris PLC
STE
| LOCK|%&HqGX | LOCK|PVf>r | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|RGX##V#j | LOCK|K?^ | $18B |
United States